These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30326245)

  • 1. Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review.
    Cornel KMC; Bongers MY; Kruitwagen RPFM; Romano A
    Mol Cell Endocrinol; 2019 Jun; 489():45-65. PubMed ID: 30326245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
    Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
    Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
    Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
    Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sulfatase pathway as estrogen supply in endometrial cancer.
    Cornel KMC; Delvoux B; Saya T; Xanthoulea S; Konings GFJ; Kruitwagen RPFM; Bongers MY; Kooreman L; Romano A
    Steroids; 2018 Nov; 139():45-52. PubMed ID: 30217785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism.
    Mercorio A; Giampaolino P; Romano A; Dällenbach P; Pluchino N
    Front Endocrinol (Lausanne); 2022; 13():950866. PubMed ID: 36204107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracrine mechanism of estrogen synthesis in breast cancer.
    Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
    Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
    Miki Y; Suzuki T; Sasano H
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):68-71. PubMed ID: 19444935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
    Smuc T; Rizner TL
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Bacallao K; Leon L; Gabler F; Soto E; Romero C; Valladares L; Vega M
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):163-9. PubMed ID: 18467089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go.
    Duncan KA
    Front Endocrinol (Lausanne); 2020; 11():345. PubMed ID: 32547495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase and intracrinology of estrogen in hormone-dependent tumors.
    Harada N
    Oncology; 1999 Oct; 57 Suppl 2():7-16. PubMed ID: 10545798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen inhibits cell proliferation through in situ production in human thymoma.
    Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
    Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases.
    Wang X; Sang X; Diorio C; Lin SX; Doillon CJ
    Mol Cell Endocrinol; 2015 Sep; 412():339-48. PubMed ID: 26044867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.